307 related articles for article (PubMed ID: 9276524)
1. Human mast cells expressing recombinant proteinase 3 (PR3) as substrate for clinical testing for anti-neutrophil cytoplasmic antibodies (ANCA).
Specks U; Wiegert EM; Homburger HA
Clin Exp Immunol; 1997 Aug; 109(2):286-95. PubMed ID: 9276524
[TBL] [Abstract][Full Text] [Related]
2. Capture-ELISA based on recombinant PR3 is sensitive for PR3-ANCA testing and allows detection of PR3 and PR3-ANCA/PR3 immunecomplexes.
Sun J; Fass DN; Hudson JA; Viss MA; Wieslander J; Homburger HA; Specks U
J Immunol Methods; 1998 Feb; 211(1-2):111-23. PubMed ID: 9617836
[TBL] [Abstract][Full Text] [Related]
3. Recombinant proteinase 3 produced in different expression systems: recognition by anti-PR3 antibodies.
van der Geld YM; Oost-Kort W; Limburg PC; Specks U; Kallenberg CG
J Immunol Methods; 2000 Oct; 244(1-2):117-31. PubMed ID: 11033024
[TBL] [Abstract][Full Text] [Related]
4. A critical evaluation of commercial immunoassays for antineutrophil cytoplasmic antibodies directed against proteinase 3 and myeloperoxidase in Wegener's granulomatosis and microscopic polyangiitis.
Csernok E; Ahlquist D; Ullrich S; Gross WL
Rheumatology (Oxford); 2002 Nov; 41(11):1313-7. PubMed ID: 12422006
[TBL] [Abstract][Full Text] [Related]
5. Clinical evaluation of a capture ELISA for detection of proteinase-3 antineutrophil cytoplasmic antibody.
Westman KW; Selga D; Bygren P; Segelmark M; Baslund B; Wiik A; Wieslander J
Kidney Int; 1998 May; 53(5):1230-6. PubMed ID: 9573537
[TBL] [Abstract][Full Text] [Related]
6. Screening for anti-neutrophil cytoplasmic antibodies (ANCA): is indirect immunofluorescence the method of choice?
Baslund B; Segelmark M; Wiik A; Szpirt W; Petersen J; Wieslander J
Clin Exp Immunol; 1995 Mar; 99(3):486-92. PubMed ID: 7882573
[TBL] [Abstract][Full Text] [Related]
7. Image analysis: a novel approach for the quantification of antineutrophil cytoplasmic antibody levels in patients with Wegener's granulomatosis.
Boomsma MM; Damoiseaux JG; Stegeman CA; Kallenberg CG; Patnaik M; Peter JB; Tervaert JW
J Immunol Methods; 2003 Mar; 274(1-2):27-35. PubMed ID: 12609530
[TBL] [Abstract][Full Text] [Related]
8. IgG from myeloperoxidase-antineutrophil cytoplasmic antibody-positive patients stimulates greater activation of primed neutrophils than IgG from proteinase 3-antineutrophil cytosplasmic antibody-positive patients.
Harper L; Radford D; Plant T; Drayson M; Adu D; Savage CO
Arthritis Rheum; 2001 Apr; 44(4):921-30. PubMed ID: 11315931
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic value of classical and atypical antineutrophil cytoplasmic antibody (ANCA) immunofluorescence patterns.
Wong RC; Silvestrini RA; Savige JA; Fulcher DA; Benson EM
J Clin Pathol; 1999 Feb; 52(2):124-8. PubMed ID: 10396240
[TBL] [Abstract][Full Text] [Related]
10. Contribution of immunofluorescence to the identification and characterization of anti-neutrophil cytoplasmic autoantibodies. The role of different fixatives.
Radice A; Vecchi M; Bianchi MB; Sinico RA
Clin Exp Rheumatol; 2000; 18(6):707-12. PubMed ID: 11138332
[TBL] [Abstract][Full Text] [Related]
11. Relevance of classic anti-neutrophil cytoplasmic autoantibody (C-ANCA)-mediated inhibition of proteinase 3-alpha 1-antitrypsin complexation to disease activity in Wegener's granulomatosis.
Dolman KM; Stegeman CA; van de Wiel BA; Hack CE; von dem Borne AE; Kallenberg CG; Goldschmeding R
Clin Exp Immunol; 1993 Sep; 93(3):405-10. PubMed ID: 8370167
[TBL] [Abstract][Full Text] [Related]
12. A review of immunofluorescent patterns associated with antineutrophil cytoplasmic antibodies (ANCA) and their differentiation from other antibodies.
Savige JA; Paspaliaris B; Silvestrini R; Davies D; Nikoloutsopoulos T; Sturgess A; Neil J; Pollock W; Dunster K; Hendle M
J Clin Pathol; 1998 Aug; 51(8):568-75. PubMed ID: 9828813
[TBL] [Abstract][Full Text] [Related]
13. Human anti-neutrophil cytoplasm autoantibodies to proteinase 3 (PR3-ANCA) bind to neutrophils.
Van Rossum AP; van der Geld YM; Limburg PC; Kallenberg CG
Kidney Int; 2005 Aug; 68(2):537-41. PubMed ID: 16014030
[TBL] [Abstract][Full Text] [Related]
14. A novel capture-ELISA for detection of anti-neutrophil cytoplasmic antibodies (ANCA) based on c-myc peptide recognition in carboxy-terminally tagged recombinant neutrophil serine proteases.
Lee AS; Finkielman JD; Peikert T; Hummel AM; Viss MA; Specks U
J Immunol Methods; 2005 Dec; 307(1-2):62-72. PubMed ID: 16242707
[TBL] [Abstract][Full Text] [Related]
15. Leucocyte membrane expression of proteinase 3 correlates with disease activity in patients with Wegener's granulomatosis.
Muller Kobold AC; Kallenberg CG; Tervaert JW
Br J Rheumatol; 1998 Aug; 37(8):901-7. PubMed ID: 9734683
[TBL] [Abstract][Full Text] [Related]
16. Low seroprevalence and poor specificity of antineutrophil cytoplasmic antibodies in tuberculosis.
Teixeira L; Mahr A; Jaureguy F; Noël LH; Nunes H; Lefort A; Barry S; Deny P; Guillevin L
Rheumatology (Oxford); 2005 Feb; 44(2):247-50. PubMed ID: 15546964
[TBL] [Abstract][Full Text] [Related]
17. Indirect immunofluorescence (IIF) of normal washed peripheral blood cells to demonstrate antineutrophil cytoplasmic antibodies (ANCA).
Paspaliaris B; Pamio M; Savige J
J Clin Pathol; 2000 Oct; 53(10):774-7. PubMed ID: 11064672
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization.
Hagen EC; Daha MR; Hermans J; Andrassy K; Csernok E; Gaskin G; Lesavre P; Lüdemann J; Rasmussen N; Sinico RA; Wiik A; van der Woude FJ
Kidney Int; 1998 Mar; 53(3):743-53. PubMed ID: 9507222
[TBL] [Abstract][Full Text] [Related]
19. The binding of proteinase 3 antineutrophil cytoplasmic antibodies (PR3-ANCA) varies in different ELISAs.
Trevisin M; Neeson P; Savige J
J Clin Pathol; 2004 Mar; 57(3):303-8. PubMed ID: 14990605
[TBL] [Abstract][Full Text] [Related]
20. Measurements of proteinase 3 and its complexes with alpha 1-proteinase inhibitor and anti-neutrophil cytoplasm antibodies (ANCA) in plasma.
Baslund B; Petersen J; Permin H; Wiik A; Wieslander J
J Immunol Methods; 1994 Oct; 175(2):215-25. PubMed ID: 7930650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]